ENGN
enGene Therapeutics Inc.
$1.78
+0.02 (+1.14%)
At close · Jul 2
Market Cap
$119.24M
Shares
66,989,466
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ENGN
10 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Select Biotechnology Portfolio | — | 232,200 | $2,347,542 | 0.04% | Long | 2026-02-28 | |
| Fidelity Nasdaq Composite Index Fund | — | 38,802 | $392,288 | 0.00% | Long | 2026-02-28 | |
| Avantis U.S. Small Cap Equity ETF | — | 32,565 | $329,232 | 0.01% | Long | 2026-02-28 | |
| NORTH SQUARE KENNEDY MICROCAP FUND | — | 11,279 | $114,031 | 0.38% | Long | 2026-02-28 | |
| TIFF MULTI-ASSET FUND | — | 10,639 | $72,452 | 0.01% | Long | 2026-03-31 | |
| JNL/DFA U.S. Small Cap Fund | — | 9,974 | $67,923 | 0.01% | Long | 2026-03-31 | |
| Small Cap Core Fund | — | 8,938 | $60,868 | 0.02% | Long | 2026-03-31 | |
| Avantis U.S. Small Cap Equity Fund | — | 5,902 | $59,669 | 0.05% | Long | 2026-02-28 | |
| Avantis U.S. Equity Fund | — | 1,125 | $11,374 | 0.00% | Long | 2026-02-28 | |
| AST Small-Cap Equity Portfolio | — | 1,376 | $9,371 | 0.00% | Long | 2026-03-31 |
Showing 1–10 of 10 positions